img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
September 20, 2024
img
img
Haoxi Health Technology Limited
(Nasdaq: HAO)

$12,000,000

Underwritten Public Offering
Sole Bookrunner

September 18, 2024
img
img
Pono Capital Two, Inc. Merger with SBC Medical Holdings, Inc.
(Nasdaq: SBC)

~$1,000,000,000

Business Combination
Capital Markets Advisor

September 17, 2024
img
img
Kairos Pharma, Ltd.
(NYSE: KAPA)

$6,200,000

Initial Public Offering
Co-Managing Underwriter

August 30, 2024
img
img
Solidion Technology, Inc.
(Nasdaq: STI)

$4,000,000

Private Placement
Exclusive Placement Agent

August 30, 2024
img
img
GigCapital7 Corp.
(Nasdaq: GIGGU)

$200,000,000

SPAC Initial Public Offering
Joint Bookrunner

August 30, 2024
img
img
INFINT Acquisition Corp. Merger with Seamless Group, Inc.
(Nasdaq: CURR)

~$400,000,000

Business Combination
Sole Underwriter

August 21, 2024
img
img
Horizon Aircraft, Inc.
(Nasdaq: HOVR)

$2,900,000

Underwritten Public Offering
Sole Bookrunner

August 14, 2024
img
NRx Pharmaceuticals, Inc.
(Nasdaq: NRXP)

$16,000,000

Private Placement
Exclusive Placement Agent

July 31, 2024
img
img
Cetus Capital Acquisition Corp. Merger with MKDWELL Tech Inc.
(Nasdaq: MKDW)

~$230,000,000

Business Combination
Capital Markets Advisor

July 29, 2024
img
img
Nature’s Miracle Holding, Inc.
(Nasdaq: NMHI)

$1,200,000

Underwritten Public Offering
Sole Bookrunner

July 15, 2024
img
img
Shineco, Inc.
(Nasdaq: SISI)

$2,000,000

Underwritten Public Offering
Sole Bookrunner

July 12, 2024
img
img
Monterey Capital Acquisition Corporation Merger With ConnectM Technology Solutions
(Nasdaq: CNTM)

~$145,000,000

Business Combination
Capital Markets Advisor

1 2 3 4 5 6 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

img

Together, let's build meaningful value.